Orchestra BioMed Holdings
Stock Forecast, Prediction & Price Target
Orchestra BioMed Holdings Financial Estimates
Orchestra BioMed Holdings Revenue Estimates
Orchestra BioMed Holdings EBITDA Estimates
Orchestra BioMed Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $-782K N/A | $3.53M 551.79% | $2.76M -21.87% | Avg: $4.01M Low: $2.74M High: $4.99M avg. 45.54% | Avg: $2.91M Low: $2.44M High: $3.31M avg. -27.48% | Avg: $4.06M Low: $3.42M High: $4.63M avg. 39.68% | Avg: $27.31M Low: $22.96M High: $31.12M avg. 571.34% |
Net Income
% change YoY
| $-23.01M N/A | $-33.60M -46.03% | $-49.12M -46.15% | Avg: $-55.42M Low: $-51.49M High: $-50.83M avg. -12.83% | Avg: $-49.42M Low: $-54.15M High: $-36.34M avg. 10.82% | Avg: $-37.21M Low: $-43.95M High: $-29.49M avg. 24.70% | Avg: $-16.94M Low: $-20.01M High: $-13.43M avg. 54.46% |
EBITDA
% change YoY
| $-21.61M N/A | $-32.43M -50.03% | $-51.21M -57.91% | Avg: $-2.00M Low: $-2.49M High: $-1.37M avg. 96.07% | Avg: $-1.45M Low: $-1.65M High: $-1.22M avg. 27.48% | Avg: $-2.03M Low: $-2.31M High: $-1.71M avg. -39.68% | Avg: $-13.65M Low: $-15.56M High: $-11.48M avg. -571.34% |
EPS
% change YoY
| -$1.13 N/A | -$2.24 -98.23% | -$1.48 33.92% | Avg: -$1.54 Low: -$1.55 High: -$1.53 avg. -4.05% | Avg: -$1.38 Low: -$1.63 High: -$1.09 avg. 10.38% | Avg: -$1.12 Low: -$1.32 High: -$0.89 avg. 18.84% | Avg: -$0.51 Low: -$0.6 High: -$0.4 avg. 54.46% |
Operating Expenses
% change YoY
| $20.81M N/A | $35.86M 72.29% | $54.08M 50.77% | Avg: $3.00M Low: $2.05M High: $3.73M avg. -94.44% | Avg: $2.17M Low: $1.83M High: $2.48M avg. -27.48% | Avg: $3.04M Low: $2.55M High: $3.46M avg. 39.68% | Avg: $20.42M Low: $17.16M High: $23.26M avg. 571.34% |
FAQ
What is Orchestra BioMed Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 19.29% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -51.49M, average is -55.42M and high is -50.83M.
What is Orchestra BioMed Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 157.27% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $2.74M, average is $4.01M and high is $4.99M.
What is Orchestra BioMed Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.91% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.55, average is -$1.54 and high is $-1.53.